Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Leunen

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Gynecologic Oncology|September 14, 2010
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?Ignace Vergote, Frederic Amant, Karin Leunen
Gynecologic Oncology|December 14, 2011
Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges?Ignace Vergote, Karin Leunen, Frédéric Amant
Gynecologic and Obstetric Investigation|June 18, 2026
Rupture of the uterine artery pseudoaneurysm causing late postpartum hemorrhage: case report and literature reviewLore Hoefnagels, Arne Vanhie, Karin Leunen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 29, 2016
Fertility Preservation Is Safe for Serous Borderline Ovarian TumorsEveline Vancraeynest, Philippe Moerman, Karin Leunen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinomaIngrid Vandenput, Ignace Vergote, Karin Leunen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2010
Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: an analysis of 163 patientsDimitris Tsolakidis, Frederic Amant, Karin Leunen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2017
Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical CancerRawand Salihi, Karin Leunen, Philippe Moerman, et al.
Gynecologic and Obstetric Investigation|July 10, 2017
Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian TumorsKobe Dewilde, Philippe Moerman, Karin Leunen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancerSofie Torfs, Isabelle Cadron, Frederic Amant, et al.
Gynecologic Oncology|June 9, 2015
Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancerRawand Salihi, Karin Leunen, Erik Van Limbergen, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Gynecologic Oncology|September 14, 2010
Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists?Ignace Vergote, Frederic Amant, Karin Leunen
Gynecologic Oncology|December 14, 2011
Primary surgery or neoadjuvant chemotherapy in ovarian cancer: what is the value of comparing apples with oranges?Ignace Vergote, Karin Leunen, Frédéric Amant
Gynecologic and Obstetric Investigation|June 18, 2026
Rupture of the uterine artery pseudoaneurysm causing late postpartum hemorrhage: case report and literature reviewLore Hoefnagels, Arne Vanhie, Karin Leunen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 29, 2016
Fertility Preservation Is Safe for Serous Borderline Ovarian TumorsEveline Vancraeynest, Philippe Moerman, Karin Leunen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 13, 2009
Leuven dose-dense paclitaxel/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinomaIngrid Vandenput, Ignace Vergote, Karin Leunen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 2010
Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: an analysis of 163 patientsDimitris Tsolakidis, Frederic Amant, Karin Leunen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 3, 2017
Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I-II Cervical CancerRawand Salihi, Karin Leunen, Philippe Moerman, et al.
Gynecologic and Obstetric Investigation|July 10, 2017
Staging with Unilateral Salpingo-Oophorectomy and Expert Pathological Review Result in No Recurrences in a Series of 81 Intestinal-Type Mucinous Borderline Ovarian TumorsKobe Dewilde, Philippe Moerman, Karin Leunen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 10, 2012
Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancerSofie Torfs, Isabelle Cadron, Frederic Amant, et al.
Gynecologic Oncology|June 9, 2015
Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancerRawand Salihi, Karin Leunen, Erik Van Limbergen, et al.
Pageof 8